ESIF cont...
Tracks
Track 1
| Wednesday, October 22, 2025 |
| 4:05 PM - 4:50 PM |
Details
Presentations continue...
Presentation 8: Advancing a novel antibody drug conjugate to treat cancer
Presented by: Dr. Kay Myo Min, Research Associate / Project Manager, University Of South Australia, DesmoX Pty Ltd
Presentation 9: A Novel Checkpoint Biologic for Interferon Driven Autoimmune Diseases (Interferonopathies)
Presented by: Prof. Claudia Nold, Group Head: Interventional Immunology, Monash University and Hudson Institute of Medical Research
Presentation 10: New treatments for refractory epilepsies
Presented by: Mr. Pradeep Sadasivan Pillai, Senior Manager, Commercialisation University Of South Australia
Presentation 11: Fine-Tuning Cardiac Contractility: A First-in-Class Troponin Modulator for Hypertrophic Cardiomyopathy
Presented by: Dr. Adam Stephenson, Associate, Uniquest Pty Limited